JP6581564B2 - クエン酸塩を含有した飲料 - Google Patents

クエン酸塩を含有した飲料 Download PDF

Info

Publication number
JP6581564B2
JP6581564B2 JP2016502531A JP2016502531A JP6581564B2 JP 6581564 B2 JP6581564 B2 JP 6581564B2 JP 2016502531 A JP2016502531 A JP 2016502531A JP 2016502531 A JP2016502531 A JP 2016502531A JP 6581564 B2 JP6581564 B2 JP 6581564B2
Authority
JP
Japan
Prior art keywords
beverage
mmol
citrate
urinary
pyridoxine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016502531A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016513474A (ja
JP2016513474A5 (enExample
Inventor
ゴールドファーブ，デイヴィッド，エス．
アイズナー，ブライアン
アスプリン，ジョン
ストーラー，マーシャル，エル．
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
University of California Berkeley
Original Assignee
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California San Diego UCSD filed Critical University of California San Diego UCSD
Publication of JP2016513474A publication Critical patent/JP2016513474A/ja
Publication of JP2016513474A5 publication Critical patent/JP2016513474A5/ja
Application granted granted Critical
Publication of JP6581564B2 publication Critical patent/JP6581564B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A23L2/66—Proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A23L2/68—Acidifying substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
JP2016502531A 2013-03-15 2014-03-14 クエン酸塩を含有した飲料 Active JP6581564B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361793442P 2013-03-15 2013-03-15
US61/793,442 2013-03-15
PCT/US2014/027736 WO2014152789A1 (en) 2013-03-15 2014-03-14 Citrate containing beverage

Publications (3)

Publication Number Publication Date
JP2016513474A JP2016513474A (ja) 2016-05-16
JP2016513474A5 JP2016513474A5 (enExample) 2017-04-13
JP6581564B2 true JP6581564B2 (ja) 2019-09-25

Family

ID=51528113

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016502531A Active JP6581564B2 (ja) 2013-03-15 2014-03-14 クエン酸塩を含有した飲料

Country Status (11)

Country Link
US (4) US9278112B2 (enExample)
EP (1) EP2983783B1 (enExample)
JP (1) JP6581564B2 (enExample)
CN (1) CN105209120A (enExample)
AU (1) AU2014236553B2 (enExample)
BR (1) BR112015023495A8 (enExample)
CA (1) CA2906907C (enExample)
HK (1) HK1219070A1 (enExample)
MX (1) MX352660B (enExample)
PH (1) PH12015502150A1 (enExample)
WO (1) WO2014152789A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9278112B2 (en) * 2013-03-15 2016-03-08 New York University Citrate containing beverage
US11273140B2 (en) * 2013-06-06 2022-03-15 Stefanie A. Seixas-Mikelus Juice beverage for prevention and treatment of renal stones
ES2486441B1 (es) * 2014-04-02 2015-06-11 Universitat De Les Illes Balears Preparaciones combinadas de acidificantes urinarios e inhibidores de la cristalización y su aplicación para el tratamiento o prevención de la litiasis renal fosfática o inducida por fosfato cálcico
WO2016159897A1 (en) * 2015-04-01 2016-10-06 Ay Doğan Potassium citrate suspension
US20170035800A1 (en) * 2015-08-06 2017-02-09 Kenneth Davin Fine Reduction of Oxalate Absorption in Individuals
JP6714984B2 (ja) * 2015-08-31 2020-07-01 キリンビバレッジ株式会社 クエン酸由来の異味が低減された容器詰めクエン酸高含有酸性飲料
WO2018080986A1 (en) 2016-10-27 2018-05-03 Seixas Mikelus Stefanie A Juice beverage for prevention and treatment of renal stones
CN108125232A (zh) * 2017-03-07 2018-06-08 浙江欣诺医药有限公司 预防与治疗泌尿系结石的补充剂及其制备方法和应用
US10986857B2 (en) 2017-08-22 2021-04-27 LithoLyte Corporation Dietary supplementation with mixed alkali salts
US11259553B2 (en) 2017-08-22 2022-03-01 Litholyte Corporation, Llc Dietary supplementation with mixed alkali salts
CN108887682A (zh) * 2018-06-09 2018-11-27 夏志君 柠檬酸钠制成柠檬酸钠养生粉及其应用
KR20230005819A (ko) * 2020-04-14 2023-01-10 닛뽕 케미파 가부시키가이샤 수면의 질의 개선제

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU165181B (enExample) * 1971-11-08 1974-07-27
US4966776A (en) 1983-04-11 1990-10-30 Board Of Regents, The University Of Texas System Compositions and methods of treating calcium renal stones
CN1033349A (zh) * 1987-11-28 1989-06-14 王龙祥 可乐系列饮料的制法
US4985593A (en) 1988-01-05 1991-01-15 Mission Pharmacal Company, Inc. Magnesium potassium citrate
US5108767A (en) * 1991-06-10 1992-04-28 Abbott Laboratories Liquid nutritional product for persons receiving renal dialysis
US5085883A (en) * 1991-06-27 1992-02-04 Abbott Laboratories Blend of dietary fiber for nutritional products
US5438042B1 (en) * 1993-10-08 1997-08-26 Sandoz Nutrition Ltd Enteral nutritional composition having amino acid profile
US20010002269A1 (en) * 1997-05-06 2001-05-31 Zhao Iris Ginron Multi-phase food & beverage
CN1438892A (zh) 2000-06-02 2003-08-27 宝洁公司 低碳水化合物组合物、其套盒及其使用方法
CN1284303A (zh) * 2000-09-08 2001-02-21 徐华春 治疗结石的饮料
US20030203072A1 (en) * 2002-04-26 2003-10-30 Team Nrg, Inc. Rehydration beverage
US20050100637A1 (en) 2003-11-12 2005-05-12 Robert Murray Carbohydrate and electrolyte replacement composition
US7323201B2 (en) 2004-06-08 2008-01-29 Tate & Lyle Ingredients Americas, Inc. Highly soluble form of tricalcium citrate, and methods of its making and use
US20050276839A1 (en) * 2004-06-10 2005-12-15 Rifkin Calman H Appetite satiation and hydration beverage
US7897192B2 (en) 2004-10-07 2011-03-01 Next Proteins, Inc. High energy carbonated protein drink and method of making
US7205018B2 (en) 2004-10-07 2007-04-17 Next Proteins, Inc. Carbonated protein drink and method of making
US20070077314A1 (en) 2005-07-15 2007-04-05 Pak Charles Y C Powder mix of potassium calcium citrate for the treatment of kidney stones and osteoporosis
JP5349744B2 (ja) * 2005-12-19 2013-11-20 松谷化学工業株式会社 ミネラル吸収促進剤、食品及び飼料
MY150223A (en) * 2007-05-18 2013-12-31 Mjn Us Holdings Llc Acidified liquid human milk supplement
GB201012539D0 (en) * 2010-07-27 2010-09-08 Savantium Ltd Nutritional compositions
WO2012068431A1 (en) 2010-11-18 2012-05-24 The Coca-Cola Company Performance enhancing sports beverage and methods of use
US9278112B2 (en) * 2013-03-15 2016-03-08 New York University Citrate containing beverage

Also Published As

Publication number Publication date
AU2014236553B2 (en) 2019-01-17
US9737564B2 (en) 2017-08-22
JP2016513474A (ja) 2016-05-16
US20140271929A1 (en) 2014-09-18
US20180169144A1 (en) 2018-06-21
EP2983783A1 (en) 2016-02-17
BR112015023495A2 (pt) 2017-07-18
US20160184349A1 (en) 2016-06-30
EP2983783A4 (en) 2016-10-26
US10258645B2 (en) 2019-04-16
WO2014152789A1 (en) 2014-09-25
CN105209120A (zh) 2015-12-30
PH12015502150A1 (en) 2016-01-25
US20170340664A1 (en) 2017-11-30
MX352660B (es) 2017-12-04
HK1219070A1 (zh) 2017-03-24
EP2983783B1 (en) 2021-04-21
US9895396B2 (en) 2018-02-20
CA2906907C (en) 2021-04-13
MX2015013221A (es) 2016-04-15
BR112015023495A8 (pt) 2019-12-03
US9278112B2 (en) 2016-03-08
AU2014236553A1 (en) 2015-11-05
CA2906907A1 (en) 2014-09-25

Similar Documents

Publication Publication Date Title
JP6581564B2 (ja) クエン酸塩を含有した飲料
Fairweather-Tait et al. Iron and calcium bioavailability of fortified foods and dietary supplements
US7063865B2 (en) Composition and method for substantially reducing the deleterious effects of alcohol on the body
Aras et al. Can lemon juice be an alternative to potassium citrate in the treatment of urinary calcium stones in patients with hypocitraturia? A prospective randomized study
JP2000511054A (ja) クレアチンを含む組成物における改良または関連する改良
CN1329256C (zh) 矿物质强化系统
Nouvenne et al. Dietary treatment of nephrolithiasis
Castellani et al. Dietary management of hypocitraturia in children with urolithiasis: results from a systematic review
US10986857B2 (en) Dietary supplementation with mixed alkali salts
US9458039B2 (en) Production process for a zinc enriched drinking water, composition and packaged water
JP2008182948A (ja) 亜鉛含有飲料
US20090155442A1 (en) Method for enhancing delivery and uniformity of concentration of dietary ingredients
Tuokkola et al. Assessment and management of magnesium and trace element status in children with CKD stages 2–5, on dialysis and post-transplantation: Clinical practice points from the Pediatric Renal Nutrition Taskforce
US20090130261A1 (en) Vit-A-Cup
JPH05276904A (ja) 小児用飲料組成物
Gibbs Manufactured complementary foods for infant and young child feeding in Asia: micronutrient adequacy and improvement
US11259553B2 (en) Dietary supplementation with mixed alkali salts
Vir et al. Iron deficiency and iron deficiency anemia in young children
US20150351443A1 (en) Hydrating compositions
ITFI20100146A1 (it) Bevanda preparabile in modo estemporaneo per l'integrazione dello iodio nelle diete alimentari
CN109963575A (zh) 用于预防和治疗肾结石的果汁饮料
JP2013538823A (ja) 体力増進用（ｆｏｒｓｔｒｅｎｇｔｈ）カルシウム強化組成物、栄養補助水、及びその調製方法
CA2611659A1 (en) Method for enhancing delivery and uniformity of concentration of dietary ingredients

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170313

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170313

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20180124

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180221

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180507

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20190123

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190523

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20190523

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20190614

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190814

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190830

R150 Certificate of patent or registration of utility model

Ref document number: 6581564

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250